Cargando…
Fibrinogen is associated with EGFR mutation status and lymphatic metastasis in non-small cell lung cancer
In the previous decade, tyrosine kinase inhibitors (TKIs) have demonstrated significant effects in patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations. However, sufficient tumor tissue for genetic testing cannot always be obtained in clinical setti...
Autores principales: | Guan, Jian, Xiao, Nan, Qiu, Chun, Li, Qin, Chen, Min, Zhang, Yao, Dai, Yong, Li, Lu, Zhang, Yue, Yang, Mi, Chen, Long, Liu, Lai Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312965/ https://www.ncbi.nlm.nih.gov/pubmed/30655825 http://dx.doi.org/10.3892/ol.2018.9652 |
Ejemplares similares
-
(18)F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer
por: Guan, Jian, et al.
Publicado: (2016) -
Lymphangiogenesis, Lymphatic Endothelial Cells and Lymphatic Metastasis in Head and Neck Cancer — A Review of Mechanisms
por: Zhang, Zhuang, et al.
Publicado: (2010) -
Evidence that vitronectin is a potent migration-enhancing factor for cancer cells chaperoned by fibrinogen: a novel view of the metastasis of cancer cells to low-fibrinogen lymphatics and body cavities
por: Schneider, Gabriela, et al.
Publicado: (2016) -
Hepatic fibrinogen storage disease and hypofibrinogenemia caused by fibrinogen Aguadilla mutation: a case report
por: Gu, Leilei, et al.
Publicado: (2020) -
Relationship between EGFR gene mutation and local metastasis of resectable lung adenocarcinoma
por: Nie, Yunqiang, et al.
Publicado: (2017)